ライフサイエンスコーパス: foramen

1 oop of the mental nerve mesial to the mental foramen.

2 jor optic nerve blood vessels at the scleral foramen.

3 skull ossification and persistent calvarial foramen.

4 a mean of 11.4 mm from the greater palatine foramen.

5 facial nerve transection at the stylomastoid foramen.

6 sterior crista (PC) and the utriculosaccular foramen.

7 that eventually exited through the nutrient foramen.

8 e meninges and lining the anterior lacerated foramen.

9 to the SN, and the SN in the greater sciatic foramen.

10 induce blood vessels from a small root canal foramen.

11 e the location of the accessory infraorbital foramen (AIOF) with reference to accessible external lan

12 e right atrium may result in widening of the foramen and consequently, cause serious conditions due t

13 pect to verifying the position of the mental foramen and validating the presence of an anterior loop

14 ior medial pterygoid tubercle, mesial mental foramen, and narrow corpus place it closer to early mode

15 Pertinent muscles, blood supply, foramen, and nerve innervations that may be encountered

16 terior to, posterior to, or above the mental foramen; and prior to placing an implant anterior to the

17 III) was noticed, especially over the mental foramen area.

18 on Area and the size of the femoral nutrient foramen as proxies.

19 cells were also hypoplastic, leaving an open foramen at birth.

20 hown by ROI 2 and 3 anteriorly to the mental foramen bilaterally, p = 0.001, and p = 0.006.

21 We trace the origin of the calvarial foramen defect in Msx2 mutant mice to a group of skeleto

22 lars, while they are close to the mandibular foramen in Ank (+/+) mice.

23 heterozygous loss of Twist function causes a foramen in the skull vault similar to that caused by los

24 or vena cava subsequently passed through the foramen into the left atrium.

25 The mental foramen is a strategically important landmark during ost

26 lip sensations are preventable if the mental foramen is located and this knowledge is employed when p

27 position when an anterior loop of the mental foramen is suspected of being present or if it is unclea

28 Ding, Fischer, and co-authors developed the foramen lacerum impingement of trigeminal nerve root (FL

29 syndrome, skull base fractures involving the foramen lacerum, neck soft tissue injury, or neurologica

30 However, it has unilateral mandibular foramen lingular bridging, an apparently derived Neander

31 blood flow (CBF) and ventriculostomy defect, foramen magnum (FM), and cerebral aqueduct CSF flow.

32 o assess cerebrospinal fluid movement at the foramen magnum and lateral ventricle during both regular

33 nal fluid movement than controls at both the foramen magnum and lateral ventricle.

34 rdiac 1st and 2nd harmonics) at the level of foramen magnum during spontaneous versus yogic breathing

35 e displacement of the cerebellum through the foramen magnum into the spinal canal, is one of the most

36 lacement of the cerebellar tonsils below the foramen magnum into the spinal canal.

37 ght) were injected intracisternally into the foramen magnum of rats under anesthesia.

38 In these disorders, spinal canal and foramen magnum stenosis can cause serious neurologic com

39 Spinal canal and foramen magnum stenosis in heterozygous achondroplasia p

40 Tonsillar herniation, foramen magnum stenosis, and severe osteomyelitis of the

41 nal cord tumor extending from just above the foramen magnum to C6.

42 h tonsils extending more than 5 mm below the foramen magnum were classified by the neurosurgeon as sy

43 death (all intracranial structures above the foramen magnum), cerebral death (all supratentorial stru

44 ntrol of the location and orientation of the foramen magnum, and changes in the breadth of the basioc

45 Besides a relatively anterior foramen magnum, humans differ from apes in the lateral s

46 e length of the clivus, the AP length of the foramen magnum, the AP length of the posterior fossa, th

47 atient group, except of the AP length of the foramen magnum, were statistically significantly lower t

48 of a chronic catheter introduced through the foramen magnum.

49 splacement and net flow, particularly at the foramen magnum.

50 tricle and both pathways contributing to the foramen magnum.

51 ion on the cranial base anterolateral to the foramen magnum.

52 lumbar vertebrae, loss of synchondroses, and foramen-magnum shape anomalies.

53 The mental foramen may be oval or round and is usually located apic

54 The foramen may not appear on conventional radiographs, and

55 the position, number, and size of the mental foramen, mental nerve anatomy, and consequences of nerve

56 Measurements of the mental foramen (MF) included height (MF-H), width (MF-W), and l

57 men that is deeper than the safety zone, the foramen must be probed to exclude the possibility that a

58 al nerve may be present mesial to the mental foramen needs to be considered before implant surgery to

59 , and their typical location adjacent to the foramen of Monro.

60 Hernias through the foramen of Winslow are extremely rare, accounting for 0.

61 Herniation through the foramen of Winslow is a difficult diagnosis and must not

62 lated at its entry to the lesser sac via the foramen of Winslow was confirmed.

63 ed" as a search platform using the keywords "foramen of Winslow" and "hernia".

64 ith strangulated ileum herniated through the foramen of Winslow.

65 on of the inferior alveolar nerve and mental foramen on panoramic and periapical films prior to impla

66 in 50 consecutive patients with a sublabral foramen or Buford complex at arthroscopy.

67 sensitivity of MR for diagnosing a sublabral foramen or Buford complex was 0.94 (47 of 50 patients, 9

68 and accuracy of MR for depicting a sublabral foramen or Buford complex were calculated along with 95%

69 ), and the presence of a posterior pneumatic foramen or fossa (absent in most tetanurans, but sporadi

70 , 0.95 to 1.21), atrial septal defect/patent foramen ovale (1.04, 0.88 to 1.24), neural tube defect (

71 .5% in patient with ECs; P<0.001) and patent foramen ovale (4.6% versus 13.5%; P=0.002).

72 m-type atrial septal defect (n=12) or patent foramen ovale (n=5) by a totally endoscopic approach, ut

73 ients 18 to 60 years of age who had a patent foramen ovale (PFO) and had had a cryptogenic ischemic s

74 A causal relationship between patent foramen ovale (PFO) and migraine has been hypothesized,

75 evention of embolism in patients with patent foramen ovale (PFO) and otherwise unexplained ischemic s

76 ischemic attack presumably related to patent foramen ovale (PFO) are at risk for recurrent cerebrovas

77 The role of a patent foramen ovale (PFO) as a risk factor for ischemic stroke

78 Patent foramen ovale (PFO) can be detected in up to 43% of pati

79 The main randomized trials evaluating patent foramen ovale (PFO) closure after a presumed PFO-associa

80 dence of atrial arrhythmia (AA) after patent foramen ovale (PFO) closure and whether this complicatio

81 -documented, those for catheter-based patent foramen ovale (PFO) closure are still evolving.

82 patients who underwent transcatheter patent foramen ovale (PFO) closure for paradoxical embolism.

83 ical devices may be used "off-label." Patent foramen ovale (PFO) closure is indicated to reduce recur

84 Percutaneous transcatheter patent foramen ovale (PFO) closure is now standard practice and

85 Patent foramen ovale (PFO) closure is the gold standard for tre

86 Transcatheter patent foramen ovale (PFO) closure is the recommended treatment

87 ional studies have shown percutaneous patent foramen ovale (PFO) closure to be a safe means of reduci

88 Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke

89 served in up to 25% of patients after patent foramen ovale (PFO) closure, but its long-term influence

90 eft atrial appendage (LAA) occlusion, patent foramen ovale (PFO) closure, transcatheter aortic valve

91 Patent foramen ovale (PFO) describes a valve in the interatrial

92 The role of surgical closure of patent foramen ovale (PFO) for cerebral infarction (CI) or tran

93 close atrial septal defects (ASD) and patent foramen ovale (PFO) has a number of limitations, includi

94 Patent foramen ovale (PFO) has been associated with migraine, b

95 Adults with a patent foramen ovale (PFO) have a greater tendency to develop s

96 ss the risk of ischemic stroke from a patent foramen ovale (PFO) in the multiethnic prospective cohor

97 The efficacy of closure of a patent foramen ovale (PFO) in the prevention of recurrent strok

98 The patent foramen ovale (PFO) is a normal interatrial communicatio

99 Patent foramen ovale (PFO) is associated with cryptogenic strok

100 Patent foramen ovale (PFO) is associated with stroke, but there

101 Patent foramen ovale (PFO) is experiencing increased clinical i

102 Patent foramen ovale (PFO) is implicated in platypnea-orthodeox

103 Patent foramen ovale (PFO) is implicated in the pathogenesis of

104 astomoses (IPAVA) in humans without a patent foramen ovale (PFO) is negatively correlated with pulmon

105 Patent foramen ovale (PFO) is prevalent in patients with migrai

106 Percutaneous transcatheter closure of patent foramen ovale (PFO) is used as an alternative to surgery

107 A patent foramen ovale (PFO) may permit arterial embolization of

108 ectiveness of percutaneous closure of patent foramen ovale (PFO) plus medical therapy versus medical

109 Patent foramen ovale (PFO) prevalence was 47% in Tibetans and H

110 zed that paradoxical embolism through patent foramen ovale (PFO) should be the main mechanism.

111 factors, regular dentist visits, and patent foramen ovale (PFO) status.

112 Patent foramen ovale (PFO) was detected with contrast injection

113 -to-left shunted blood flow through a patent foramen ovale (PFO) would not be cooled.

114 A patent foramen ovale (PFO), an opening between the right and le

115 with atrial septal aneurysm (SA) and patent foramen ovale (PFO), and to determine the efficacy of me

116 to determine the association between patent foramen ovale (PFO), atrial septal aneurysm (ASA), and s

117 headache symptoms in patients with a patent foramen ovale (PFO), both of which conditions are highly

118 milder form of atrial septal defect, patent foramen ovale (PFO), exists in about one-quarter of the

119 to evaluate the relationship between patent foramen ovale (PFO), ischemic stroke, and subclinical ce

120 Controversy surrounds the issue of patent foramen ovale (PFO), stroke, and secondary prevention st

121 ulting in a right-to-left shunt via a patent foramen ovale (PFO).

122 nt ischemic stroke, and prevalence of patent foramen ovale (PFO).

123 res to repair incidentally discovered patent foramen ovale (PFO).

124 including ischaemic stroke [through a patent foramen ovale (PFO)].

125 ifty-four (86%) had effective closure of the foramen ovale (trivial or no residual shunt by echocardi

126 cted symptomatic patients, closure of patent foramen ovale after cryptogenic stroke, treatment of ins

127 The prevalence of patent foramen ovale among patients with cryptogenic stroke is

128 The association of patent foramen ovale and atrial septal aneurysm with stroke is

129 Patients with a patent foramen ovale and ischemic stroke, transient ischemic at

130 elopment of anatomic variants such as patent foramen ovale and left atrial septal pouch.

131 Patent foramen ovale and pulmonary arteriovenous shunts are ass

132 aphy identified three patients with a patent foramen ovale and right-to-left shunt flow while breathi

133 cryptogenic embolism in patients with patent foramen ovale are administration of antithrombotic medic

134 Structural heart disease and a patent foramen ovale are strongly associated with the presence

135 e closure (9 secundum ASDs and 4 with patent foramen ovale associated with a cerebral vascular accide

136 Foramen ovale blood flow (QFO = LVCO-QP) was estimated.

137 natomic structures typically regress and the foramen ovale closes after birth.

138 results using these tools to perform patent foramen ovale closure are described.

139 in 4 and repair in 2, CABG in 2, and patent foramen ovale closure in 5.

140 Evidence from trials suggests that patent foramen ovale closure is superior to medical therapy alo

141 pparent increased risk for concurrent patent foramen ovale closure or mitral or tricuspid repair.

142 Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tac

143 patients who underwent transcatheter patent foramen ovale closure to prevent recurrent cerebrovascul

144 alysis demonstrated that simultaneous patent foramen ovale closure was not associated with an increas

145 n the impact of sex on outcomes after patent foramen ovale closure, however, remains scarce.

146 left atrial appendage occlusion, and patent foramen ovale closure, profoundly differ with respect to

147 Occluder, are used for transcatheter patent foramen ovale closure.

148 k of developing device syndrome after patent foramen ovale closure.

149 th nickel hypersensitivity undergoing patent foramen ovale closure.

150 gulation for atrial fibrillation, and patent foramen ovale closure.

151 a demonstration of both technologies, patent foramen ovale creation and closure was performed in a sw

152 mainly the adult population, such as patent foramen ovale device closure and closure of postinfarct

153 aware of these variations when accessing the foramen ovale during trigeminal neuralgia interventions.

154 ients, all of whom underwent recordings with foramen ovale electrodes and scalp electroencephalogram.

155 mesial temporal activity using intracranial foramen ovale electrodes in two patients with Alzheimer'

156 Closure of a patent foramen ovale for secondary prevention of cryptogenic em

157 Patent foramen ovale has been associated with increased risk of

158 lowed by ostium secundum ASD in 6 and patent foramen ovale in 4.

159 benefit associated with closure of a patent foramen ovale in adults who had had a cryptogenic ischem

160 The Patent foramen ovale In Cryptogenic Stroke Study (PICSS) evalua

161 th warfarin or aspirin as part of the Patent Foramen Ovale in Cryptogenic Stroke Study (PICSS), based

162 s (the PRIMA [Percutaneous Closure of Patent Foramen Ovale in Migraine With Aura] and PREMIUM [Prospe

163 hocardiograms in 11 patients showed a patent foramen ovale in one patient but no systemic source of e

164 that occur in the major veins and across the foramen ovale in the circulation of the fetal lamb.

165 The foramen ovale is an essential component of the fetal cir

166 Whether closure of a patent foramen ovale is effective in the prevention of recurren

167 Patent foramen ovale is present in approximately 25% of all adu

168 e of percutaneous closure devices for patent foramen ovale is reviewed.

169 d paradoxical emboli in patients with patent foramen ovale is unknown.

170 Transcatheter closure of patent foramen ovale may prevent a substantial proportion of cr

171 e (11%), aortic valve procedure (9%), patent foramen ovale or atrial septal defect closure (23%), car

172 Whether closure of a patent foramen ovale reduces the risk of recurrence of ischemic

173 diseases causing stroke, the role of patent foramen ovale remains controversial.

174 A strong inverse relationship between foramen ovale shunt and pulmonary blood flow was noted (

175 The wide range we found in foramen ovale shunting suggests a degree of variability

176 compression sickness with concomitant patent foramen ovale that was successfully closed contrary to s

177 closure of an atrial septal defect or patent foramen ovale to assess how the procedure affected migra

178 sus stream preferentially passed through the foramen ovale to the left atrium.

179 Foramen ovale volume blood flow (left ventricular cardia

180 <.001), and DA volume blood flow (P<.01) and foramen ovale volume blood flow (P<.03) decreased.

181 cept for 19.6 +/- 2.3% of the cycle when the foramen ovale was closed during atrial contraction.

182 In the second group, the patent foramen ovale was not successfully created in 1 animal,

183 of medical therapy (895 patients) for patent foramen ovale were included.

184 theter closure or medical therapy for patent foramen ovale were required to include at least 10 patie

185 Here, we report stenting of the foramen ovale with a large, open-cell stent via percutan

186 ly assigned to undergo closure of the patent foramen ovale with the Amplatzer PFO Occluder or to rece

187 f the ten patients undergoing semi-invasive (foramen ovale) electrode monitoring reveals that for at

188 d in 47% (including 17% with isolated patent foramen ovale), and 11% had undetermined stroke etiology

189 (0, 160); umbilical vein, 134 (62, 206); and foramen ovale, 135 (37, 233).

190 16 (0, 34); umbilical vein, 29 (11, 47); and foramen ovale, 29 (7, 51).

191 (TAA), 88% had left-to-right flow across the foramen ovale, 91% had monophasic mitral inflow, and 94%

192 Patent foramen ovale, alone or together with ASA, was not assoc

193 patients had simultaneous closure of patent foramen ovale, and 19 patients had other various cardiac

194 ne prevalence of atrial fibrillation, patent foramen ovale, and arterial stenoses were also similar f

195 (RAP) score (comprising the tricuspid valve, foramen ovale, and ductus venosus Doppler).

196 persistent pulmonary hypertension, a patent foramen ovale, and free-floating right-heart thrombus ar

197 ion of the inferior vena cava, right atrium, foramen ovale, and left atrium with a guidewire and 1.8F

198 sease, presence of left common trunk, patent foramen ovale, and time for atrial fibrillation diagnosi

199 ccult paroxysmal atrial fibrillation, patent foramen ovale, aortic arch atherosclerosis, atrial cardi

200 has been reported in patients with a patent foramen ovale, carcinoid tumor of the lung, and active c

201 h cryptogenic stroke or TIA who had a patent foramen ovale, closure with a device did not offer a gre

202 One possible exception is patent foramen ovale, for which high-risk features may warrant

203 en pulmonary embolism coexists with a patent foramen ovale, increased pressure in the right atrium ma

204 rmal LV length, reversed flow in the TAA and foramen ovale, monophasic mitral inflow, and LV dysfunct

205 defect, secundum atrial septal defect/patent foramen ovale, neural tube defect, clubfoot, and oral cl

206 ing of intracranial atheroma, patent cardiac foramen ovale, or elevated levels of antiphospholipid an

207 re of secundum atrial septal defects, patent foramen ovale, patent ductus arteriosus, stent placement

208 patients with cryptogenic stroke and patent foramen ovale-related ischemic stroke to receive either

209 isolated atrial septal defect and/or patent foramen ovale.

210 ntrast transcranial doppler to detect patent foramen ovale.

211 enosus, in both venae cavae, and through the foramen ovale.

212 y arteries and migraine patients with patent foramen ovale.

213 variations influence surgical access to the foramen ovale.

214 direct inferior vena caval flow towards the foramen ovale.

215 tcomes after transcatheter closure of patent foramen ovale.

216 ts who completed echocardiography had patent foramen ovale.

217 paradoxical embolism due to existing patent foramen ovale.

218 the stent was successfully positioned in the foramen ovale.

219 cell stent was positioned in an unrestricted foramen ovale.

220 dical therapy alone or closure of the patent foramen ovale.

221 ations or percutaneous closure of the patent foramen ovale.

222 sient ischemic attack (TIA) and had a patent foramen ovale.

223 ited to pulmonary artery stenosis and patent foramen ovale.

224 Of 11 patients, 5 (45%) had a patent foramen ovale; 1 of these also had a primary lung carcin

225 utility in quantitative assessment of patent foramen ovales (PFO).

226 Patent foramen ovales (PFOs) are common congenital cardiac defe

227 Patent foramen ovales vary in both anatomical and functional si

228 All patent foramen ovales were completely closed in the first group

229 and utilizing the rib as a conduit into the foramen provided an advantage in patients with osteopeni

230 f the nose and the lower wall of the orbital foramen provided comparable results to the standard tech

231 nerve; surgical corroboration of the mental foramen's position when an anterior loop of the mental f

232 r chamber and in having the glossopharyngeal foramen separated from the metotic fissure.

233 s (FMNs) survive axotomy at the stylomastoid foramen (SMF), whereas, before postnatal day 15 (P15), d

234 s are more accurate for detecting the mental foramen than conventional radiographs.

235 hylogenetic analyses reveal an autapomorphic foramen that distinguishes it from all other troodontids

236 r of neurons with somata near the esophageal foramen that gave rise to arborizations in the protocere

237 to placing an implant anterior to the mental foramen that is deeper than the safety zone, the foramen

238 ng the cranium through bony canals and large foramens; that central neurons receiving nociceptive inf

239 trally as they progressed toward the scleral foramen (the mouse does not have a lamina cribrosa), and

240 Cdh23 is expressed in the urticulo-saccular foramen,the ductus reuniens, and Reissner's membrane, su

241 portion of the orbit primarily via the optic foramen; they travel only short distances and end blindl

242 noncontact vagal stimulation at the jugular foramen, through the internal jugular veins (extracardia

243 lear how much bone is present coronal to the foramen to establish a zone of safety (in millimeters) f

244 ined at 5-mm increments distal to the mental foramen to the ascending ramus.

245 gh the presence of a rounded and conspicuous foramen vasculare distale and the trochlea metatarsi II

246 asal process, a large and deep neurovascular foramen within the perinarial fossa, and a deep perinari